login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
CITIUS ONCOLOGY INC (CTOR) Stock News
NASDAQ:CTOR - Nasdaq -
US17331Y1091
-
Common Stock
- Currency: USD
1.74
-0.07 (-3.87%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CTOR Latest News, Press Relases and Analysis
All
Press Releases
25 days ago - By: Citius Oncology, Inc.
- Mentions:
CTXR
Citius Oncology Announces Closing of $9.0 Million Public Offering
a month ago - By: Citius Oncology, Inc.
- Mentions:
CTXR
Citius Oncology Announces Pricing of $9.0 Million Public Offering
a month ago - By: Benzinga
- Mentions:
CYCC
LIXT
CBIO
RPTX
...
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
a month ago - By: Benzinga
- Mentions:
CYCC
RPTX
BDSX
GANX
...
12 Health Care Stocks Moving In Tuesday's After-Market Session
a month ago - By: Citius Oncology, Inc.
- Mentions:
CTXR
Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora
2 months ago - By: Citius Oncology, Inc.
- Mentions:
CTXR
Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025
Please enable JavaScript to continue using this application.
